lenalidomid sandoz 10 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 10 mg / 1 kapsula - lenalidomid
lenalidomid sandoz 15 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 15 mg / 1 kapsula - lenalidomid
lenalidomid sandoz 25 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 25 mg / 1 kapsula - lenalidomid
lenalidomid sandoz 5 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 5 mg / 1 kapsula - lenalidomid
lenalidomid teva 10 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 10 mg / 1 kapsula - lenalidomid
lenalidomid teva 15 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 15 mg / 1 kapsula - lenalidomid
lenalidomid teva 25 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 25 mg / 1 kapsula - lenalidomid
lenalidomid teva 5 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 5 mg / 1 kapsula - lenalidomid
dexrapid
vetviva richter gmbh -
rekambys
janssen-cilag international nv - rilpivirine - okužbe z virusom hiv - antivirusi za sistemsko uporabo - rekambys is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (hiv 1) infection in adults who are virologically suppressed (hiv-1 rna < 50 copies/ml) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the nnrti and ini class.